Enforcement Report - Week of February 28, 2024
Alembic Pharma subsidiary, Aleor Dermaceuticals gets USFDA nod for acne gel
Aleor Dermaceuticals`s Generic Adapalene Receives Approval in the U.S.
Actavis's Generic Benzoyl Peroxide: Adapalene Receives Approval in US
Zydus Lifesciences has received final approval from the US Food and Drug Administration (FDA) to market Adapalene and Benzoyl Peroxide Topical Gel, 0.3%/2.5%, a company statement notified.
Zydus Pharma`s Generic Adapalene|Benzoyl Peroxide Receives Approval in the U.S.
Sol-Gel’s work to expand the treatment options for patients with a skin condition has paid off, with the FDA approving a product based on its tech.
NESS ZIONA, Israel and ZUG, Switzerland, April 25, 2022 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, announced today the Food and Drug Administration (FDA) approval of its drug product, EPSOLAY®, a proprietary cream formulation of benzoyl peroxide, 5%, for the treatment of inflammatory lesions of rosacea in adults.
Enforcement Report - Week of December 22, 2021